Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Printer Friendly Page Follow BioNews on Twitter BioNews RSS feed

 

Login




News


New Alzheimer's disease genes discovered

11 April 2011

By Alison Cranage

Appeared in BioNews 603

International scientists including researchers at Cardiff University, UK and the University of Pennsylvania, USA have discovered five genetic variations associated with Alzheimer's disease. The findings are published in two papers in the journal Nature Genetics.

The studies, led by Professor Julie Williams at Cardiff University's MRC Centre for Neuropsychiatric Genetics, and Professor Gerard Schellenberg at the University of Pennsylvania's School of Medicine compared the genetic makeup of tens of thousands of people with Alzheimer's disease to healthy volunteers.

Together, the studies uncovered five genetic variations associated with the common form of Alzheimer's disease, affecting people over 65 years old, bringing the total to ten. The variations discovered are in genes that are involved in the immune system, the way our brains deal with cholesterol and how cells absorb and use large molecules.

The findings should help researchers focus on the causes of Alzheimer's disease and provide new treatment targets. It is not thought that the genetic variations have a large effect on a person's risk of developing Alzheimer's, but genetic susceptibility combined with lifestyle, environmental factors and ageing are all thought to be involved in causing Alzheimer's disease.

Professor Williams said: 'What's exciting about our findings is that the genetic variations we've found all fit together. Five of the recently identified genes all have a role to play in the immune system. Four have functions at the cell surface and three are involved in moving fats around inside our cells. It's likely that these processes have a key role to play in causing Alzheimer's disease'.

'It's an exciting time for genetic research. Modern technology has allowed us to complete this work and we're really getting to the crux of what causes Alzheimer's. We hope this will give us valuable new leads in the hunt for effective treatments'.

Rebecca Wood, Chief Executive of Alzheimer's Research UK, which part-funded the study, said: 'UK scientists are leading the field in our understanding of the genetics of Alzheimer's. These findings are a step towards defeating dementia. We are yet to find ways of halting this devastating condition, but this work is likely to spark off new ideas, collaborations and more research'.

 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

20 February 2012 - by Dr Caroline Hirst 
Skin cells from volunteers with Down's syndrome have been turned into brain cells in order to provide a new model for researchers to study Alzheimer's disease...[Read More]
24 October 2011 - by George Frodsham 
Researchers have fully sequenced the genome of a woman who lived to be 115 years old. She is the longest-surviving person to have their DNA sequenced and the data may help to unlock the secrets of longer life. Initial investigations suggest that the woman may have had genes which provided protection from diseases such as dementia...[Read More]

27 September 2010 - by Alison Cranage 
US scientists have identified a gene which they suggest is associated with Alzheimer's and could help uncover the causes of the disease....[Read More]
19 July 2010 - by Chris Chatterton 
Middle-aged people without Alzheimer's disease who have a 'high risk' variant of the TOMM40 gene are more likely to have poorer memory, new research findings suggest...[Read More]
28 September 2009 - by Jay Stone 
Dr R. Scott Turner and his team of the Memory Disorders Program at Georgetown University, US, have begun recruiting patients to take part in a gene therapy trial, which hopes to test whether gene therapy using the nerve growth factor (NGF) gene could be used to slow the progression of Alzheimer's disease...[Read More]
07 September 2009 - by Ailsa Stevens 
British and French researchers this week announced the discovery of three new genes linked to late-onset Alzheimer's disease, certain variations in which may increase a person's risk of developing the disease by 10-15 per cent. If new drugs could be developed to counter the effects of these mutations, it could help to prevent 20 per cent, the equivalent of 100,000 cases, of Alzheimer's disease in the UK per year, the researchers claim....[Read More]
19 July 2009 - by Adam Fletcher 
Findings published last week suggest that people are not troubled upon learning they are at higher risk of developing Alzheimer’s disease. Writing in the New England Journal of Medicine, researchers at the Boston University School of Medicine, US, led by Dr Robert Green, measured participants’ anxiety levels following results of a genetic test. The paper arrives amidst debate on how harmful direct-to-customer genetics testing - offered by companies such as 23andMe and DeCodeMe - might actuall...[Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.


submit to reddit
Delicious delicious
Facebook

Share on Tumblr


Printer Friendly Page


BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read


The Progress Educational Trust has been shortlisted for the Charity Times Awards 2011

Good Fundraising Code


Advertise your products and services HERE - click for further details